Nerve growth factor synthesis in cultured rat iris: modulation by endogenous transmitter substances.
Organ cultures of rat iris show a characteristic change in the levels of both nerve growth factor (NGF) and its mRNA: a rapid but transient initial increase is followed by a smaller but persistently elevated NGF synthesis. This time course may be influenced by release of a factor(s) from degenerating nerve terminals and/or by the lack of some factor(s) repressing NGF synthesis in vivo. We therefore analyzed the influence of biogenic amine transmitter substances and putative neuropeptides on this elevation of NGF synthesis in cultured iris. The marked increase of NGF synthesis seen initially in culture was not completely mimicked by any of the substances tested. A specific increase in NGF production up to 150% of control was observed only with cGMP. We also obtained some evidence that reaction to trauma following the culture procedure could enhance NGF production: cutting of irides into small pieces increased NGF production in culture up to 250% of control and, vice versa, treatment with 1 microM dexamethasone decreased NGF production to about 60% of control. However, the sympathetic neurotransmitter norepinephrine (NE) decreased both NGF and its mRNA levels specifically in a dose-dependent manner (0.01-1 mM) to a minimum of about 25% of control. In situ hybridization with mRNA(NGF)-specific probes showed that in cultures of dissociated iris cells all cells were capable of expressing mRNA(NGF), but that 0.1 mM NE preferentially decreased expression of mRNA(NGF) in smooth muscle cells. Thus, our results indicate that the sympathetic transmitter NE is capable of downregulating NGF synthesis in the target cells of sympathetic neurons.
Hellweg
R
R
Max-Planck-Institute for Psychiatry, Department of Neurochemistry, Planegg-Martinsried, Federal Republic of Germany.
Bandtlow
C E
CE
Heumann
R
R
Korsching
S
S
D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D020148:Butyric Acid; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D007498:Iris / Q000378:metabolism*; D008297:Male; D008715:Methionine / Q000378:metabolism; D009414:Nerve Growth Factors / Q000096:biosynthesis* / Q000235:genetics; D009638:Norepinephrine / Q000494:pharmacology; D009924:Organ Culture Techniques; D015347:RNA Probes; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D002087:Butyrates; D009414:Nerve Growth Factors; D015347:RNA Probes; D012333:RNA, Messenger; D020148:Butyric Acid; C016276:8-bromocyclic GMP; D003995:Dibutyryl Cyclic GMP; D008715:Methionine; D006152:Cyclic GMP; D009638:Norepinephrine